选择可溶性免疫标志物以确定新型阴道产品安全性的考量因素。
Considerations for Choosing Soluble Immune Markers to Determine Safety of Novel Vaginal Products.
作者信息
Happel Anna-Ursula, Sivro Aida, Liebenberg Lenine, Passmore Jo Ann, Mitchell Caroline M
机构信息
Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
出版信息
Front Reprod Health. 2022 May 17;4:899277. doi: 10.3389/frph.2022.899277. eCollection 2022.
Abstract
Several soluble cytokines have been associated with microbicide-induced cervicovaginal inflammation, non-optimal vaginal microbiota, and risk of HIV acquisition. Many of these biomarkers are used in preclinical assays to estimate the safety of vaginally applied products. However, there are currently no validated biomarkers to evaluate the safety of novel vaginal products in clinical trials. This hinders the rapid and rational selection of novel products being tested in first-in-human trials. We reviewed available literature to assess how best to select and measure soluble immune markers to determine product safety in first in human clinical trials of novel vaginal products.
摘要
几种可溶性细胞因子与杀微生物剂引起的宫颈阴道炎症、不理想的阴道微生物群以及感染艾滋病毒的风险有关。其中许多生物标志物用于临床前检测，以评估阴道应用产品的安全性。然而，目前尚无经过验证的生物标志物来评估新型阴道产品在临床试验中的安全性。这阻碍了在首次人体试验中对新型产品进行快速合理的选择。我们查阅了现有文献，以评估如何最好地选择和测量可溶性免疫标志物，从而在新型阴道产品的首次人体临床试验中确定产品安全性。
相似文献
1
Considerations for Choosing Soluble Immune Markers to Determine Safety of Novel Vaginal Products.选择可溶性免疫标志物以确定新型阴道产品安全性的考量因素。
Front Reprod Health. 2022 May 17;4:899277. doi: 10.3389/frph.2022.899277. eCollection 2022.
2
Biomarkers of cervicovaginal inflammation for the assessment of microbicide safety.用于评估杀微生物剂安全性的宫颈阴道炎症生物标志物。
Sex Transm Dis. 2009 Mar;36(3 Suppl):S84-91. doi: 10.1097/OLQ.0b013e3181994191.
3
Guiding the vaginal microbicide trials with biomarkers of inflammation.利用炎症生物标志物指导阴道微生物杀灭剂试验。
J Acquir Immune Defic Syndr. 2004 Oct;37 Suppl 3(Suppl 3):S184-93.
4
Evaluation of immunological markers of ovine vaginal irritation: Implications for preclinical assessment of non-vaccine HIV preventive agents.评价绵羊阴道刺激的免疫标志物：对非疫苗 HIV 预防制剂临床前评估的意义。
J Reprod Immunol. 2017 Nov;124:38-43. doi: 10.1016/j.jri.2017.09.014. Epub 2017 Oct 13.
5
Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid.隔膜与润滑剂或酸化杀微生物凝胶联合使用的安全性分析：对宫颈阴道液中炎症和先天免疫标志物的影响。
Am J Reprod Immunol. 2009 Feb;61(2):121-9. doi: 10.1111/j.1600-0897.2008.00670.x.
6
Clinical development of microbicides for the prevention of HIV infection.用于预防艾滋病毒感染的杀微生物剂的临床开发。
Curr Pharm Des. 2004;10(3):315-36. doi: 10.2174/1381612043386374.
7
Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.乳酸和短链脂肪酸引起的宫颈阴道上皮细胞的不同免疫反应与最佳和非最佳阴道微生物群有关。
Front Cell Infect Microbiol. 2020 Jan 10;9:446. doi: 10.3389/fcimb.2019.00446. eCollection 2019.
8
L-selectin and P-selectin are novel biomarkers of cervicovaginal inflammation for preclinical mucosal safety assessment of anti-HIV-1 microbicide.L-选择素和 P-选择素是新型的宫颈阴道炎症生物标志物，用于抗 HIV-1 杀微生物剂的临床前黏膜安全性评估。
Antimicrob Agents Chemother. 2012 Jun;56(6):3121-32. doi: 10.1128/AAC.05950-11. Epub 2012 Mar 5.
9
Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.撒哈拉以南非洲女性特定生殖道免疫标志物与阴道微生物群的横断面分析及其与艾滋病病毒风险和预防的相关性
Clin Vaccine Immunol. 2015 May;22(5):526-38. doi: 10.1128/CVI.00762-14. Epub 2015 Mar 11.
10
The importance of the vaginal delivery route for antiretrovirals in HIV prevention.阴道给药途径的抗逆转录病毒药物在艾滋病预防中的重要性。
Ther Deliv. 2011 Dec;2(12):1535-50. doi: 10.4155/tde.11.126.
引用本文的文献
1
Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections.关于长效醋酸甲羟孕酮对阴道黏膜终点的影响及其与性传播感染相关性的最新进展。
Curr HIV/AIDS Rep. 2023 Aug;20(4):251-260. doi: 10.1007/s11904-023-00662-0. Epub 2023 Jun 21.
本文引用的文献
1
Vaginal cytokine profile and microbiota before and after lubricant use compared with condomless vaginal sex: a preliminary observational study.比较使用润滑剂前后与无保护阴道性交前后阴道细胞因子谱和微生物群：一项初步观察性研究。
BMC Infect Dis. 2021 Sep 18;21(1):973. doi: 10.1186/s12879-021-06512-x.
2
Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women.近期精液暴露对女性细胞因子反应和细菌性阴道病的影响。
Front Immunol. 2021 Jun 9;12:695201. doi: 10.3389/fimmu.2021.695201. eCollection 2021.
3
Transient association between semen exposure and biomarkers of genital inflammation in South African women at risk of HIV infection.南非感染 HIV 风险女性中精液暴露与生殖系统炎症生物标志物之间的短暂关联。
J Int AIDS Soc. 2021 Jun;24(6):e25766. doi: 10.1002/jia2.25766.
4
Observational cohort study of the effect of a single lubricant exposure during transvaginal ultrasound on cell-shedding from the vaginal epithelium.经阴道超声单次使用润滑剂对阴道上皮细胞脱落影响的观察性队列研究。
PLoS One. 2021 May 3;16(5):e0250153. doi: 10.1371/journal.pone.0250153. eCollection 2021.
5
Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women.即时检测和治疗性传播感染及细菌性阴道病对南非年轻女性生殖道炎症细胞因子的影响。
Sex Transm Infect. 2021 Dec;97(8):555-565. doi: 10.1136/sextrans-2020-054740. Epub 2021 Feb 19.
6
Cervical-Vaginal Microbiome and Associated Cytokine Profiles in a Prospective Study of HPV 16 Acquisition, Persistence, and Clearance.前瞻性研究 HPV16 感染、持续感染和清除过程中宫颈阴道微生物组和相关细胞因子谱
Front Cell Infect Microbiol. 2020 Sep 25;10:569022. doi: 10.3389/fcimb.2020.569022. eCollection 2020.
7
Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.测试南非的监管框架 - 一项商业益生菌补充剂对细菌性阴道病女性标准治疗的单盲随机试点试验。
BMC Infect Dis. 2020 Jul 10;20(1):491. doi: 10.1186/s12879-020-05210-4.
8
Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.随机试验表明，Lactin-V 可预防细菌性阴道病复发。
N Engl J Med. 2020 May 14;382(20):1906-1915. doi: 10.1056/NEJMoa1915254.
9
Matrix Metalloproteinases Expressed in Response to Bacterial Vaginosis Disrupt the Endocervical Epithelium, Increasing Transmigration of HIV.细菌性阴道病诱导表达的基质金属蛋白酶破坏宫颈内上皮细胞，增加 HIV 的穿入。
Infect Immun. 2020 Mar 23;88(4). doi: 10.1128/IAI.00041-20.
10
Apoptosis of vaginal epithelial cells in clinical samples from women with diagnosed bacterial vaginosis.诊断为细菌性阴道病的女性临床样本中阴道上皮细胞的凋亡。
Sci Rep. 2020 Feb 6;10(1):1978. doi: 10.1038/s41598-020-58862-2.
Zotero 插件